He Huang Selected Research

Neutropenia

11/2022	Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study.
8/2021	Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
1/2021	Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies.
11/2020	Fluconazole is as effective as other anti-mold agents in preventing early invasive fungal disease after allogeneic stem cell transplantation: assessment of antifungal therapy in haematological disease in China.
6/2019	Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
8/2017	Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
9/2015	Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years.
6/2015	Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
2/2015	Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China.
2/2014	Hyperthyroidism with concurrent FMS-like tyrosine kinase 3-internal tandem duplication-positive acute promyelocytic leukemia: A case report and review of the literature.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

He Huang Research Topics

Disease

240	Neoplasms (Cancer) 04/2024 - 05/2002
61	Leukemia 04/2024 - 11/2004
58	Inflammation (Inflammations) 04/2024 - 08/2007
53	Infections 04/2024 - 11/2002
49	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 11/2004
45	Hematologic Neoplasms (Hematological Malignancy) 05/2024 - 10/2003
42	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 04/2002
39	Fibrosis (Cirrhosis) 04/2024 - 04/2010
36	Multiple Myeloma 02/2023 - 06/2004
34	Heart Failure 01/2024 - 07/2007
32	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 11/2004
31	Neoplasm Metastasis (Metastasis) 01/2024 - 04/2002
30	Lymphoma (Lymphomas) 02/2024 - 05/2002
28	Myocardial Infarction 04/2024 - 09/2009
26	Atrial Fibrillation 01/2024 - 11/2005
25	Hypoxia (Hypoxemia) 02/2024 - 04/2004
24	Cardiac Arrhythmias (Arrythmia) 12/2023 - 05/2009
23	Carcinogenesis 01/2024 - 09/2003
22	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 12/2007
21	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 03/2011
21	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 03/2009
19	Body Weight (Weight, Body) 03/2024 - 02/2010
19	Cytokine Release Syndrome 03/2024 - 01/2016
19	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 11/2003
18	Stomach Neoplasms (Stomach Cancer) 08/2023 - 12/2005
17	Sepsis (Septicemia) 12/2024 - 01/2013
17	Cardiomegaly (Heart Hypertrophy) 01/2024 - 02/2010
16	Hemorrhage 02/2024 - 09/2012
16	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 01/2012
16	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 11/2010
15	Pain (Aches) 02/2024 - 08/2006
15	Obesity 01/2024 - 01/2017
14	B-Cell Lymphoma (Lymphoma, B Cell) 09/2023 - 02/2004
14	Residual Neoplasm 07/2023 - 11/2003
14	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2020 - 10/2003
13	Breast Neoplasms (Breast Cancer) 01/2024 - 12/2008
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 12/2002
13	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 08/2009
13	Hypertension (High Blood Pressure) 01/2023 - 07/2007
13	Neutropenia 11/2022 - 08/2011
13	Carcinoma (Carcinomatosis) 03/2019 - 11/2002
12	Hypertrophy 04/2024 - 01/2014
11	Disease Progression 04/2024 - 04/2004
11	Glioma (Gliomas) 04/2024 - 07/2005
11	COVID-19 03/2024 - 01/2020
11	Ischemia 11/2023 - 01/2009
11	Nasopharyngeal Carcinoma 01/2023 - 12/2003
10	Atrial Remodeling 11/2023 - 09/2010
10	Thrombosis (Thrombus) 09/2023 - 08/2007
9	Lung Neoplasms (Lung Cancer) 05/2024 - 02/2013
9	Mycoses (Diseases, Fungus) 08/2021 - 05/2013
9	Adenocarcinoma 04/2021 - 11/2002

Drug/Important Bio-Agent (IBA)

115	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2005
87	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2016
52	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2005
31	CytokinesIBA 03/2024 - 05/2010
21	Messenger RNA (mRNA)IBA 11/2022 - 06/2004
20	MicroRNAs (MicroRNA)IBA 03/2023 - 10/2008
20	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2008
19	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 09/2012
17	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 11/2002
17	Interleukin-6 (Interleukin 6)IBA 01/2024 - 06/2004
15	AntigensIBA 11/2022 - 05/2008
14	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 02/2023 - 06/2020
14	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2021 - 02/2004
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2024 - 09/2009
13	B-Cell Maturation AntigenIBA 02/2023 - 06/2020
12	Therapeutic UsesIBA 03/2024 - 06/2010
12	CalciumIBA 03/2024 - 04/2002
12	Peptides (Polypeptides)IBA 02/2024 - 09/2009
12	Small Interfering RNA (siRNA)IBA 09/2020 - 02/2006
11	EnzymesIBA 12/2023 - 08/2011
11	Rituximab (Mabthera)FDA Link 11/2023 - 08/2009
11	Long Noncoding RNAIBA 01/2023 - 12/2016
10	LipopolysaccharidesIBA 12/2024 - 12/2014
10	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 06/2016
10	IronIBA 04/2024 - 04/2010
10	Imatinib Mesylate (Gleevec)FDA Link 02/2024 - 05/2009
10	LipidsIBA 01/2024 - 05/2013
10	Indicators and Reagents (Reagents)IBA 01/2023 - 10/2011
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 10/2011
9	NF-kappa B (NF-kB)IBA 04/2024 - 08/2006
9	Oxygen (Dioxygen)IBA 01/2024 - 05/2007
9	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 12/2023 - 01/2017
9	Prednisone (Sone)FDA LinkGeneric 01/2023 - 10/2011
9	CollagenIBA 01/2021 - 04/2010
9	Angiotensin IIIBA 10/2018 - 04/2010
8	Histones (Histone)IBA 03/2024 - 01/2015

Therapy/Procedure

196	Therapeutics 05/2024 - 05/2002
86	Hematopoietic Stem Cell Transplantation 04/2024 - 01/2010
82	Drug Therapy (Chemotherapy) 04/2024 - 08/2002
39	Transplantation 04/2024 - 10/2003
32	Immunotherapy 04/2024 - 01/2017
20	Stem Cell Transplantation 02/2024 - 06/2004
16	Stents 10/2023 - 03/2011
16	Radiotherapy 01/2023 - 03/2011
11	Neoadjuvant Therapy 11/2023 - 11/2003
10	Deep Brain Stimulation 07/2016 - 05/2005
9	Ligation 12/2024 - 09/2009
9	Catheter Ablation 01/2022 - 07/2006